TARDBP and Alzheimer disease: Our study extends on those findings by demonstrating that STMN2 and UNC13A disruption from TDP-43 loss-of-function is detected in large RNA-seq datasets and can distinguish between Alzheimer’s disease patients with and without TDP-43 pathology.